Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index

NCT ID: NCT00366197

Last Updated: 2014-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-01-31

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial examines weaning outcomes using the rapid shallow breathing index rate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We hypothesize that the trend of the Rapid Shallow Breathing Index or RSBI rate, is a better predictor of weaning outcome than the RSBI as a single value during the weaning trial. patients are recruited during a weaning trial on t-piece and the RSBI during what the RSBI is measured periodically. The outcome is ventilatory status at 24 hours after the weaning trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rapid Shallow Breathing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Requires need of mechanical ventilation for \> 48 hours with a tube size no smaller than 7.5

Exclusion Criteria

* Healthy volunteers
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Atlantic Health System

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stanley Fiel, MD

Role: PRINCIPAL_INVESTIGATOR

Atlantic Health System

Harris Rana, MD

Role: PRINCIPAL_INVESTIGATOR

Atlantic Health System

Salvatore Ruggiero, MD

Role: PRINCIPAL_INVESTIGATOR

Atlantic Health System

Erwin Oei, MD

Role: PRINCIPAL_INVESTIGATOR

Atlantic Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Morristown Memorial Hospital

Morristown, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Rapid Shallow Breathing Index

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.